Neurosoft Raises Funding for Innovative Technology
Geneva-based Neurosoft, an EPFL spinout, has raised an undisclosed amount in a funding round led by undisclosed investors. The company, which specializes in soft, stretchable cortical electrode arrays, will use the funds to further develop its technology.
Details
The funding round, which took place in 2023, saw participation from undisclosed investors. The exact amount raised was not disclosed. The funds will be used to advance the development of Neurosoft’s soft cortical electrode array technology.
Company Background
Neurosoft, founded as a spinout from EPFL, is headquartered in Geneva with a US subsidiary in New York. The company specializes in developing soft, stretchable cortical electrode arrays that can be used in various medical applications.
Market Context
This funding round is significant as it highlights the growing interest in innovative medical technologies. The development of soft, stretchable cortical electrode arrays could revolutionize the field of neuroscience, offering new possibilities for brain-computer interfaces and other medical applications.
The decision to invest in Neurosoft reflects a recognition of the potential of their technology and the expertise of their team. It also underscores the importance of collaboration between academia and industry in driving innovation.
If you are building a hardware product, BangDesign’s product design team can help.
Source: X / Twitter